Use of Impinging Jet to Improve Scalability in the Preparation of the ABBV-154 Drug-Linker

Abstract

The final step in the preparation of the ABBV-154 drug-linker is a global acidic deprotection of three tert-butyl protecting groups that proceeds through several intermediates and is complicated by acetal epimerization, which generates an undesired diastereomer. This complex reaction was initially optimized in a batch setup, but scaling issues prompted the development of a flow process with an impinging jet mixing element. Initial studies utilized commercially available Y-mixers for small-scale experiments; however, clogging of the mixer was difficult to avoid. A three-dimensional (3D) printed Y-mixer impinging jet was created for lab development to avoid this issue and scale down the geometry of the plant-scale jet. The impinging process was executed in the manufacturing environment at kilogram scale, maintaining the desired diastereoselectivity, and reversed-phase chromatography enabled purification of the drug-linker. This paper discusses the key parameters examined to ensure successful scaleup of a mixing-sensitive reaction that demonstrated superior selectivity in flow compared to the batch process.

Development and Execution of a Scalable Route to an Immunology ADC Drug-Linker for ABBV-154

“…Despite the significant increase in scale, both reactions yielded higher dr values than the initial manufacturing reactions performed at ∼40 mL/min (Figure ). Overall, the inverse addition reaction allowed preparation of significant quantities of crude drug-linker 1 with high diastereoselectivity …”